Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stem Cell Researchers Appalled As Judge Blocks Loosened Guidelines

Executive Summary

The National Institutes of Health, trade groups and the stem cell research community reacted swiftly and in united fashion condemning an Aug. 23 federal court decision that blocks a broad range of work being done with human embryonic stem cells, and leaves projects in progress scrambling for new sources of funding

You may also be interested in...



Legal News, In Brief: Copaxone, AngioMax, Cipro, Botox, OxyContin

Teva Wins Ruling On Copaxone Patents

Legal News, In Brief: Copaxone, AngioMax, Cipro, Botox, OxyContin

Teva Wins Ruling On Copaxone Patents

Despite Advances, Regenerative Medicine Faces Funding Crisis

Stem-cell and regenerative medicine firms are scrambling to find business models to harness the field's nascent, rapidly evolving science. Companies deep into clinical trials are still looking for pharma partnerships. Earlier stage biotechs are trying to turn their platforms into research revenue as they look to non-profit, government, and private funding sources to advance their preclinical therapeutic programs. Whatever the model, worries abound that the financial woes of the next couple of years could blunt hard-earned momentum.

Related Content

Topics

UsernamePublicRestriction

Register

PS052570

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel